Free Trial

Docusign Inc. (NASDAQ:DOCU) Shares Sold by Achmea Investment Management B.V.

Docusign logo with Computer and Technology background

Achmea Investment Management B.V. lowered its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 15.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 172,453 shares of the company's stock after selling 30,925 shares during the period. Achmea Investment Management B.V. owned approximately 0.09% of Docusign worth $14,037,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in DOCU. FMR LLC increased its position in shares of Docusign by 178.2% in the fourth quarter. FMR LLC now owns 6,101,024 shares of the company's stock worth $548,726,000 after acquiring an additional 3,908,139 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Docusign by 283.9% during the fourth quarter. Invesco Ltd. now owns 3,447,275 shares of the company's stock worth $310,048,000 after purchasing an additional 2,549,310 shares in the last quarter. Norges Bank acquired a new position in shares of Docusign during the fourth quarter worth about $223,196,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of Docusign by 201.6% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,158,311 shares of the company's stock worth $194,118,000 after purchasing an additional 1,442,639 shares in the last quarter. Finally, Jericho Capital Asset Management L.P. lifted its stake in shares of Docusign by 34.0% during the fourth quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock worth $427,642,000 after purchasing an additional 1,205,500 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Insider Transactions at Docusign

In other news, insider James P. Shaughnessy sold 7,500 shares of the business's stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total transaction of $609,825.00. Following the completion of the transaction, the insider now owns 45,875 shares of the company's stock, valued at approximately $3,730,096.25. The trade was a 14.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Teresa Briggs sold 534 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $74.37, for a total transaction of $39,713.58. Following the transaction, the director now directly owns 8,805 shares of the company's stock, valued at approximately $654,827.85. This trade represents a 5.72% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 54,052 shares of company stock worth $4,101,776. 1.01% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on DOCU. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a research report on Friday, June 6th. UBS Group reduced their price target on Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Royal Bank Of Canada reissued a "sector perform" rating and set a $90.00 price target on shares of Docusign in a research report on Friday, March 14th. Robert W. Baird reduced their price target on Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Finally, Wedbush lowered their target price on Docusign from $100.00 to $85.00 and set a "neutral" rating for the company in a research note on Thursday, June 12th. Twelve research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $89.77.

Read Our Latest Report on Docusign

Docusign Trading Up 1.2%

NASDAQ DOCU traded up $0.92 on Friday, hitting $76.47. 3,300,976 shares of the stock traded hands, compared to its average volume of 2,865,058. The stock has a 50-day moving average of $82.17 and a 200 day moving average of $85.17. Docusign Inc. has a twelve month low of $48.80 and a twelve month high of $107.86. The company has a market capitalization of $15.45 billion, a P/E ratio of 14.46, a price-to-earnings-growth ratio of 28.65 and a beta of 1.14.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, June 5th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analyst estimates of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%. The business's revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.82 EPS. As a group, equities research analysts expect that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign declared that its Board of Directors has initiated a stock repurchase plan on Thursday, June 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to buy up to 6.6% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's board believes its stock is undervalued.

Docusign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines